MedPath

贵州心意药业有限责任公司

Ownership
-
Established
1995-11-06
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

Rotundine Tablets

Product Name
罗通定片
Approval Number
国药准字H52020476
Approval Date
Aug 19, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H52020322
Approval Date
Aug 19, 2020
NMPA

Compound Paracetamol and Chlorphenamine Maleate Granules

Product Name
复方氨酚那敏颗粒
Approval Number
国药准字H52020531
Approval Date
Aug 19, 2020
NMPA

Pentoxyverine Citrate Tablets

Product Name
枸橼酸喷托维林片
Approval Number
国药准字H52020329
Approval Date
Aug 19, 2020
NMPA

Tetracycline Hydrochloride Tablets

Product Name
盐酸四环素片
Approval Number
国药准字H52020323
Approval Date
Aug 19, 2020
NMPA

Trepibutone Tablets

Product Name
曲匹布通片
Approval Number
国药准字H52020690
Approval Date
Aug 19, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H52020311
Approval Date
Aug 19, 2020
NMPA

Chloramphenicol Tablets

Product Name
氯霉素片
Approval Number
国药准字H52020316
Approval Date
Aug 19, 2020
NMPA

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H52020312
Approval Date
Aug 19, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H52020326
Approval Date
Aug 19, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.